This patent covers the basic technology for the production of Multikine, a drug which is in testing for various cancers.
Japan is one of the larg-est pharmaceutical markets in the world.
Multikine is a natural mixture of human immune system regulators called cytokines. Multikine is currently being tested in head and neck cancer and prostate cancer. Multikine is also scheduled to go into a clinical study with HIV infected patients in the first quarter of 1997. It is developing Multikine for the treatment of cancers and other immunodeficiency diseases. Site developed by HWS, Inc.